journal article Open Access Nov 06, 2019

The multifaceted role of CARD9 in inflammatory bowel disease

View at Publisher Save 10.1111/jcmm.14770
Abstract
AbstractInflammatory bowel disease (IBD) involves a dysregulated immune response to the gut microbiota. Emerging evidence has demonstrated that dysfunctions in caspase recruitment domain‐containing protein 9 (CARD9) may contribute to the pathogenesis of IBD. Interestingly, an allelic series of Card9 variants have both a common predisposing and rare protective function in IBD patients. In this review, we provide mechanistic insights into the role of the CARD9 adaptor molecule in intestinal inflammation and determine a potential CARD9‐targeting therapeutic approach against IBD.
Topics

No keywords indexed for this article. Browse by subject →

References
33
[4]
CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands

Bruno Lamas, Mathias L Richard, Valentin Leducq et al.

Nature Medicine 10.1038/nm.4102
[7]
Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease

Floris Imhann, Arnau Vich Vila, Marc Jan Bonder et al.

Gut 10.1136/gutjnl-2016-312135
[8]
Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease

Manuel A Rivas, Mélissa Beaudoin, Agnes Gardet et al.

Nature Genetics 10.1038/ng.952
[12]
Wang Z "Genetic association between CARD9 variants and inflammatory bowel disease was not replicated in a Chinese Han population" Int J Clin Exp Pathol (2015)
[28]
Tryptophan Catabolites from Microbiota Engage Aryl Hydrocarbon Receptor and Balance Mucosal Reactivity via Interleukin-22

Teresa Zelante, Rossana G. Iannitti, Cristina Cunha et al.

Immunity 10.1016/j.immuni.2013.08.003
Cited By
43
Metrics
43
Citations
33
References
Details
Published
Nov 06, 2019
Vol/Issue
24(1)
Pages
34-39
License
View
Cite This Article
Ping Luo, Zhiwen Yang, Bin Chen, et al. (2019). The multifaceted role of CARD9 in inflammatory bowel disease. Journal of Cellular and Molecular Medicine, 24(1), 34-39. https://doi.org/10.1111/jcmm.14770
Related

You May Also Like